Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash PLC Regulatory News (KP2)

Share Price Information for Kore Potash PLC (KP2)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.20 (7.14%)
Bid:
2.90
Ask:
3.10
Spread: 0.20 (6.897%)
Market Cap: £155.28m
KP2 Live PriceLast checked at - London Stock Exchange

Intraday Kore Potash PLC Share Chart

Appendix 5B

25 Oct 2021 07:01

RNS Number : 0256Q
Kore Potash PLC
25 October 2021
Β 

Appendix 5B

Mining exploration entity or oil and gas exploration entityquarterly cash flow report

Name of entity

Kore Potash Plc

ABN

Β 

Quarter ended ("current quarter")

621 843 614

30 September 2021

Β 

Consolidated statement of cash flows

Current quarter$US'000

Year to date (9 months)$US'000

1.

Cash flows from operating activities

-

-

1.1

Receipts from customers

1.2

Payments for

-

-

(a) exploration & evaluation (if expensed)

(b) development

-

-

(c) production

-

-

(d) staff costs

(265)

(768)

(e) administration and corporate costs

(442)

(974)

1.3

Dividends received (see noteΒ 3)

-

-

1.4

Interest received

5

15

1.5

Interest and other costs of finance paid

(1)

(3)

1.6

Income taxes paid

-

-

1.7

Government grants and tax incentives

-

-

1.8

Intercompany payments

-

-

1.9

Net cash from / (used in) operating activities

(703)

(1,730)

2.

Cash flows from investing activities

Β 

Β 

-

Β 

Β 

-

2.1

Payments to acquire:

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

-

(d) exploration & evaluation (if capitalised)

(681)

(4,173)

(e) investments

-

-

(f) other non-current assets

-

-

2.2

Proceeds from the disposal of:

Β 

-

Β 

-

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

-

(d) investments

-

-

(e) other non-current assets

-

-

2.3

Cash flows from loans to other entities

-

-

2.4

Dividends received (see noteΒ 3)

-

-

2.5

Other (provide details if material)

-

-

2.6

Net cash from / (used in) investing activities

(681)

(4,173)

3.

Cash flows from financing activities

Β 

2

Β 

14,027

3.1

Proceeds from issues of equity securities (excluding convertible debt securities)

3.2

Proceeds from issue of convertible debt securities

(28)

(959)

3.3

Proceeds from exercise of options

-

-

3.4

Transaction costs related to issues of equity securities or convertible debt securities

-

-

3.5

Proceeds from borrowings

-

-

3.6

Repayment of borrowings

-

-

3.7

Transaction costs related to loans and borrowings

-

-

3.8

Dividends paid

-

-

3.9

Other (provide details if material)

-

-

3.10

Net cash from / (used in) financing activities

(26)

13,068

4.

Net increase / (decrease) in cash and cash equivalents for the period

4.1

Cash and cash equivalents at beginning of period

14,163

5,555

4.2

Net cash from / (used in) operating activities (itemΒ 1.9 above)

(703)

(1,730)

4.3

Net cash from / (used in) investing activities (itemΒ 2.6 above)

(681)

(4,173)

4.4

Net cash from / (used in) financing activities (itemΒ 3.10 above)

(26)

13,068

4.5

Effect of movement in exchange rates on cash held

(133)

(100)

4.6

Cash and cash equivalents at end of period

12,620

12,620

Β 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarter$US'000

Previous quarter$US'000

5.1

Bank balances

12,620

14,163

5.2

Call deposits

-

-

5.3

Bank overdrafts

-

-

5.4

Other (provide details)

-

-

5.5

Cash and cash equivalents at end of quarter (should equal itemΒ 4.6 above)

12,620

14,163

Β 

6.

Payments to related parties of the entity and their associates

Current quarter$USD'000

6.1

Aggregate amount of payments to related parties and their associates included in itemΒ 1

198

6.2

Aggregate amount of payments to related parties and their associates included in itemΒ 2

-

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

Β 

7.

Financing facilitiesNote: the term "facility' includes all forms of financing arrangements available to the entity.

Add notes as necessary for an understanding of the sources of finance available to the entity.

Total facility amount at quarter end$US'000

Amount drawn at quarter end$US'000

7.1

Loan facilities

-

-

7.2

Credit standby arrangements

-

-

7.3

Other (please specify)

-

-

7.4

Total financing facilities

-

-

7.5

Unused financing facilities available at quarter end

-

7.6

Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

Β 

Β 

Β 

Β 

8.

Estimated cash available for future operating activities

$US'000

8.1

Net cash from / (used in) operating activities (ItemΒ 1.9)

(703)

8.2

Capitalised exploration & evaluation (Item 2.1(d))

(681)

8.3

Total relevant outgoings (ItemΒ 8.1 + ItemΒ 8.2)

(1,384)

8.4

Cash and cash equivalents at quarter end (ItemΒ 4.6)

12,620

8.5

Unused finance facilities available at quarter end (ItemΒ 7.5)

-

8.6

Total available funding (ItemΒ 8.4 + ItemΒ 8.5)

12,620

8.7

Estimated quarters of funding available (ItemΒ 8.6 divided by ItemΒ 8.3)

9.1

8.8

If ItemΒ 8.7 is less than 2Β quarters, please provide answers to the following questions:

1. Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer: N/A

Β 

Β 

2. Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer: N/A

Β 

3. Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?

Answer: N/A

Β 

Β 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing RuleΒ 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

Β 

Β 

Date: 25 October 2021

Β 

Authorised by: By the Board

(Name of body or officer authorising release - see noteΒ 4)

Β 

Notes

1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity's activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing RuleΒ 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

4. If this report has been authorised for release to the market by your board of directors, you can insert here: "By the board". If it has been authorised for release to the market by a committee of your board of directors, you can insert here: "By the [name of board committee - eg Audit and Risk Committee]". If it has been authorised for release to the market by a disclosure committee, you can insert here: "By the Disclosure Committee".

5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendationΒ 4.2 of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCBIBDGUSDDGBS
Date   Source Headline
3rd Mar 20217:00 amRNSCDI Monthly Movement
18th Feb 20217:00 amRNSUpdated presentation available
12th Feb 20212:06 pmRNSSecond Price Monitoring Extn
12th Feb 20212:00 pmRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSCDI Monthly Movement
29th Jan 20217:00 amRNSReview of Operations for Q4 2020
15th Jan 20217:00 amRNSIssue of Equity
6th Jan 20217:00 amRNSCDI Monthly Movement
24th Dec 202012:40 pmRNSSecond Price Monitoring Extn
24th Dec 202012:36 pmRNSPrice Monitoring Extension
23rd Dec 20209:06 amRNSSecond Price Monitoring Extn
23rd Dec 20209:00 amRNSPrice Monitoring Extension
22nd Dec 20202:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 20209:05 amRNSSecond Price Monitoring Extn
22nd Dec 20209:00 amRNSPrice Monitoring Extension
22nd Dec 20208:50 amRNSASX share price query
14th Dec 20207:00 amRNSCorrespondence received from Minister of Mines
3rd Dec 20209:00 amRNSCDI Monthly Movement
2nd Dec 20207:00 amRNSDX Project - DFS Progress Update
24th Nov 20207:00 amRNSChange in Non-Executive Director
12th Nov 20207:00 amRNSCorrection: Updated DX Pre-Feasibility Study
9th Nov 20207:00 amRNSUpdated DX Pre-Feasibility Study
5th Nov 20207:00 amRNSCDI Monthly Movement
27th Oct 20207:43 amRNSReview of Operations for Q3 2020
22nd Oct 20207:00 amRNSDrilling Campaign at DX Project Commences
14th Oct 20207:00 amRNSGovernment approval to drill at DX Project
13th Oct 20207:00 amRNSIssue of Equity
5th Oct 202010:49 amRNSCDI Monthly Movement
30th Sep 20207:00 amRNSWork commences on DFS for the DX Project
22nd Sep 20201:00 pmRNSExpiry of Unlisted Options
21st Sep 202011:30 amRNSPDMR Shareholding
21st Sep 20207:00 amRNSNotice under section 708A(5)(e)
18th Sep 202011:00 amRNSResults of General Meeting and Issue of Shares
14th Sep 20207:00 amRNSRemote access to GM
8th Sep 20207:15 amRNSConfirming participation in Proposed Fundraise
8th Sep 20207:00 amRNSFINANCIAL REPORT FOR HALF YEAR ENDED 30 JUNE 2020
4th Sep 20207:00 amRNSCDI Monthly Movement
2nd Sep 202011:00 amRNSNotice of GM
26th Aug 20209:05 amRNSSecond Price Monitoring Extn
26th Aug 20209:00 amRNSPrice Monitoring Extension
26th Aug 20207:00 amRNSResults of Proposed Fundraise
25th Aug 20204:35 pmRNSProposed Fundraise to raise a minimum of US$7m
5th Aug 20207:00 amRNSCDI Monthly Movement
30th Jul 20207:00 amRNSReview of Operations for Q2 2020
6th Jul 20207:00 amRNSCDI Monthly Movement
26th Jun 202012:30 pmRNSResult of AGM
26th Jun 202010:00 amRNSCEO’s presentation following AGM
25th Jun 20207:00 amRNSIssue of Equity, Performance Rights and Options
24th Jun 20207:00 amRNSRemote access to AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.